SG10202004908UA - Compound for use in the prevention and treatment of neurodegenerative diseases - Google Patents
Compound for use in the prevention and treatment of neurodegenerative diseasesInfo
- Publication number
- SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- compound
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15196984 | 2015-11-30 | ||
| EP16156775.5A EP3207925A1 (fr) | 2016-02-22 | 2016-02-22 | Composé destiné à être utilisé dans la prévention et le traitement de maladies neurodégénératives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202004908UA true SG10202004908UA (en) | 2020-06-29 |
Family
ID=57539219
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
| SG10202004908UA SG10202004908UA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11179358B2 (fr) |
| EP (2) | EP3383381B1 (fr) |
| JP (2) | JP7033073B2 (fr) |
| CN (1) | CN108601758A (fr) |
| AU (1) | AU2016364308B2 (fr) |
| CA (1) | CA3003841A1 (fr) |
| DK (1) | DK3383381T3 (fr) |
| ES (1) | ES2804541T3 (fr) |
| HU (1) | HUE050096T2 (fr) |
| IL (1) | IL259383B (fr) |
| MX (1) | MX2018006631A (fr) |
| PT (1) | PT3383381T (fr) |
| SG (2) | SG11201803422RA (fr) |
| WO (1) | WO2017093363A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021025665A2 (pt) * | 2019-06-18 | 2022-04-12 | Univ Wien | Uma preparação que compreende um composto de calixareno e o uso médico do mesmo, alimento, ração ou composição cosmética que compreende um composto de calixareno |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5489612A (en) | 1991-08-23 | 1996-02-06 | The University Of Alabama At Birmingham Research Foundation | Calixarene chloride-channel blockers |
| FR2782007B1 (fr) * | 1998-08-05 | 2001-02-23 | Centre Nat Rech Scient | Utilisation des calix(n)arenes pour le traitement des maladies fibrotiques |
| US8506959B2 (en) * | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| CN101052417A (zh) * | 2004-08-09 | 2007-10-10 | 艾兰制药公司 | 突触核蛋白病以及淀粉样变性病的预防和治疗 |
| FR2888937B1 (fr) | 2005-07-21 | 2012-10-26 | Biomerieux Sa | Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes |
| CN103735554B (zh) * | 2006-03-29 | 2018-03-20 | 维斯塔实验室有限公司 | 蛋白聚集抑制剂 |
| WO2013134371A1 (fr) | 2012-03-06 | 2013-09-12 | Neuropore Therapies, Inc. | Procédés et composés pouvant être utilisés pour traiter les maladies neurodégénératives |
-
2016
- 2016-11-30 EP EP16809318.5A patent/EP3383381B1/fr active Active
- 2016-11-30 ES ES16809318T patent/ES2804541T3/es active Active
- 2016-11-30 MX MX2018006631A patent/MX2018006631A/es unknown
- 2016-11-30 WO PCT/EP2016/079353 patent/WO2017093363A1/fr active Application Filing
- 2016-11-30 CN CN201680069632.0A patent/CN108601758A/zh active Pending
- 2016-11-30 DK DK16809318.5T patent/DK3383381T3/da active
- 2016-11-30 US US15/779,559 patent/US11179358B2/en active Active
- 2016-11-30 CA CA3003841A patent/CA3003841A1/fr active Pending
- 2016-11-30 JP JP2018546767A patent/JP7033073B2/ja active Active
- 2016-11-30 SG SG11201803422RA patent/SG11201803422RA/en unknown
- 2016-11-30 HU HUE16809318A patent/HUE050096T2/hu unknown
- 2016-11-30 AU AU2016364308A patent/AU2016364308B2/en active Active
- 2016-11-30 SG SG10202004908UA patent/SG10202004908UA/en unknown
- 2016-11-30 EP EP20168424.8A patent/EP3735965A1/fr not_active Withdrawn
- 2016-11-30 IL IL259383A patent/IL259383B/en unknown
- 2016-11-30 PT PT168093185T patent/PT3383381T/pt unknown
-
2021
- 2021-12-10 JP JP2021200877A patent/JP2022027864A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018535272A (ja) | 2018-11-29 |
| SG11201803422RA (en) | 2018-06-28 |
| MX2018006631A (es) | 2019-01-30 |
| US11179358B2 (en) | 2021-11-23 |
| CN108601758A (zh) | 2018-09-28 |
| JP2022027864A (ja) | 2022-02-14 |
| CA3003841A1 (fr) | 2017-06-08 |
| ES2804541T3 (es) | 2021-02-08 |
| JP7033073B2 (ja) | 2022-03-09 |
| EP3383381B1 (fr) | 2020-04-08 |
| AU2016364308A1 (en) | 2018-05-17 |
| IL259383B (en) | 2022-07-01 |
| EP3383381A1 (fr) | 2018-10-10 |
| PT3383381T (pt) | 2020-07-03 |
| HUE050096T2 (hu) | 2020-11-30 |
| EP3735965A1 (fr) | 2020-11-11 |
| IL259383A (en) | 2018-07-31 |
| DK3383381T3 (da) | 2020-07-13 |
| WO2017093363A1 (fr) | 2017-06-08 |
| US20200360315A1 (en) | 2020-11-19 |
| AU2016364308B2 (en) | 2022-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| HUE047952T2 (hu) | Ellenanyag-drog konjugátum és alkalmazása rák kezelésében történõ alkalmazásra | |
| PL3277280T3 (pl) | Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych | |
| IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use | |
| GB201617064D0 (en) | Compounds and their therapeutic use | |
| FI3197556T3 (fi) | Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi | |
| EP3107534A4 (fr) | Compositions et procédés pour le traitement de maladies neurodégénératives | |
| EP3283457A4 (fr) | Composés et procédés pour le traitement de maladies neurodégénératives | |
| PT3120852T (pt) | Agente preventivo e/ou terapêutico para doenças imunitárias | |
| EP3208262A4 (fr) | Composés dérivés d'acrylate de 3-alkylamine-1h-indolyle et leur utilisation dans le traitement de maladies neurodégénératives | |
| HK1246271A1 (zh) | 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途 | |
| PT3413870T (pt) | Igmesina para utilização no tratamento de doença de alzheimer | |
| IL252493B (en) | Compounds for use in the prevention or treatment of cancer | |
| IL249440B (en) | Pharmaceutical compounds and preparations containing them for the treatment of neurodegenerative diseases | |
| EP3377062C0 (fr) | Composés d'aminonaphthoquinone pour le traitement et/ou la prévention de maladies de fibrose | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| PT3191112T (pt) | Compostos de dipeptidilcetoamida e sua utilização para o tratamento e/ou prevenção da acumulação de gordura | |
| HK1252359A1 (zh) | 用於治療疼痛的曲唑酮和加巴噴丁的組合 | |
| IL257689A (en) | Pharmacological preparations and methods for the treatment of diseases associated with hypoxia | |
| GB201518489D0 (en) | Methods for the treatment and prevention of ebola |